Gene · 8288
Papers2,629
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,121 to 1,140 of 2,629
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma. | Front Med (Lausanne) | 2017 | 28913336 | PubTator, text mining | PubMed |
| Eosinophilic biomarkers for detection of acute exacerbation of chronic obstructive pulmonary disease with or without pulmonary embolism. | Exp Ther Med | 2017 | 28912870 | PubTator, text mining | PubMed |
| Functions of tissue-resident eosinophils. | Nat Rev Immunol | 2017 | 28891557 | PubTator, text mining | PubMed |
| Mepolizumab Attenuates Airway Eosinophil Numbers, but Not Their Functional Phenotype, in Asthma. | Am J Respir Crit Care Med | 2017 | 28862877 | PubTator, text mining | PubMed |
| Baseline mineralizing surface determines the magnitude of the bisphosphonate effect on cortical bone mineralization in postmenopausal osteoporotic patients. | J Musculoskelet Neuronal Interact | 2017 | 28860420 | PubTator, text mining | PubMed |
| Editorial: Searching for definitive evidence of the role of eosinophils in lung disease: are we there yet? | J Leukoc Biol | 2017 | 28860205 | PubTator, text mining | PubMed |
| Identification of novel targets for multiple myeloma through integrative approach with Monte Carlo cross-validation analysis. | J Bone Oncol | 2017 | 28856086 | PubTator, text mining | PubMed |
| Rapid Evolution of Primate Type 2 Immune Response Factors Linked to Asthma Susceptibility. | Genome Biol Evol | 2017 | 28854632 | PubTator, text mining | PubMed |
| Identification of CALM as the potential serum biomarker for predicting the recurrence of nasopharyngeal carcinoma using a mass spectrometry-based comparative proteomic approach. | Int J Mol Med | 2017 | 28849027 | PubTator, text mining | PubMed |
| Platelet-Eosinophil Interactions As a Potential Therapeutic Target in Allergic Inflammation and Asthma. | Front Med (Lausanne) | 2017 | 28848732 | PubTator, text mining | PubMed |
| Bidirectional Mast Cell-Eosinophil Interactions in Inflammatory Disorders and Cancer. | Front Med (Lausanne) | 2017 | 28791287 | PubTator, text mining | PubMed |
| Novel Modulators of Asthma and Allergy: Exosomes and MicroRNAs. | Front Immunol | 2017 | 28785260 | PubTator, text mining | PubMed |
| Pharmacological modulation of reactive oxygen species (ROS) improves the airway hyperresponsiveness by shifting the Th1 response in allergic inflammation induced by ovalbumin. | Free Radic Res | 2017 | 28776450 | PubTator, text mining | PubMed |
Erratum: "Trans-basement membrane migration of eosinophils induced by LPS-stimulated neutrophils from human peripheral blood in vitro" Fuyumi Nishihara, Kazuyuki Nakagome, Takehito Kobayashi, Toru Noguchi, Ryuichiro Araki, Yoshitaka Uchida, Tomoyuki Soma and Makoto Nagata. ERJ Open Res 2015; 1: 00003-2015. | ERJ Open Res | 2017 | 28775989 | PubTator, text mining | PubMed |
| Eicosapentaenoic acid prevents arterial calcification in klotho mutant mice. | PLoS One | 2017 | 28771600 | PubTator, text mining | PubMed |
| Cysteinyl Leukotrienes in Eosinophil Biology: Functional Roles and Therapeutic Perspectives in Eosinophilic Disorders. | Front Med (Lausanne) | 2017 | 28770202 | PubTator, text mining | PubMed |
| Effects of Mesenchymal Stem Cell Derivatives on Hematopoiesis and Hematopoietic Stem Cells. | Adv Pharm Bull | 2017 | 28761818 | PubTator, text mining | PubMed |
| Recent advances in understanding eosinophil biology. | F1000Res | 2017 | 28751971 | PubTator, text mining | PubMed |
| Pathological manifestations in lymphatic filariasis correlate with lack of inhibitory properties of IgG4 antibodies on IgE-activated granulocytes. | PLoS Negl Trop Dis | 2017 | 28742098 | PubTator, text mining | PubMed |
| The Biology of Eosinophils and Their Role in Asthma. | Front Med (Lausanne) | 2017 | 28713812 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8288/papers?page=57